Moderna (MRNA) Insider Trading & Ownership $39.39 -0.17 (-0.43%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Moderna (NASDAQ:MRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage15.70%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$81.38 M Get MRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Moderna stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRNA Insider Buying and Selling by Quarter Ad Porter & CompanyVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Moderna Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/9/2024Shannon Thyme KlingerInsiderSell529$44.68$23,635.72 12/3/2024Shannon Thyme KlingerInsiderSell112$43.30$4,849.60 12/3/2024Stephen HogePresidentSell314$43.30$13,596.20 11/29/2024Shannon Thyme KlingerInsiderSell1,418$42.79$60,676.22 11/29/2024Stephen HogePresidentSell291$42.79$12,451.89 10/7/2024James M MockCFOSell715$60.12$42,985.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/3/2024Shannon Thyme KlingerInsiderSell114$76.99$8,776.86 9/3/2024Stephen HogePresidentSell318$76.99$24,482.82 8/29/2024Shannon Thyme KlingerInsiderSell162$78.03$12,640.86 8/29/2024Stephen HogePresidentSell300$78.03$23,409.00 8/28/2024James M MockCFOSell1,321$79.39$104,874.19 8/12/2024Stephen HogePresidentSell254$84.10$21,361.40 7/31/2024Noubar AfeyanDirectorSell15,000$119.96$1,799,400.00 7/24/2024Noubar AfeyanDirectorSell15,000$117.80$1,767,000.00 7/17/2024Noubar AfeyanDirectorSell15,000$122.84$1,842,600.00 7/15/2024Stephen HogePresidentSell15,000$121.12$1,816,800.00 7/10/2024Noubar AfeyanDirectorSell15,000$117.08$1,756,200.00 7/8/2024James M MockCFOSell689$118.24$81,467.36 6/26/2024Noubar AfeyanDirectorSell15,000$127.22$1,908,300.00 6/17/2024Stephen HogePresidentSell15,000$138.16$2,072,400.00 6/11/2024Noubar AfeyanDirectorSell202,832$148.34$30,088,098.88 6/10/2024Shannon Thyme KlingerInsiderSell5,178$148.09$766,810.02 6/5/2024Noubar AfeyanDirectorSell15,000$151.25$2,268,750.00 5/29/2024Noubar AfeyanDirectorSell20,000$145.08$2,901,600.00 5/29/2024Stephen HogePresidentSell341$144.50$49,274.50 5/28/2024James M MockCFOSell648$162.47$105,280.56 5/28/2024Shannon Thyme KlingerInsiderSell1,296$162.47$210,561.12 5/22/2024Noubar AfeyanDirectorSell15,000$157.57$2,363,550.00 5/15/2024Noubar AfeyanDirectorSell15,000$127.32$1,909,800.00 5/10/2024Stephen HogePresidentSell255$120.96$30,844.80 5/8/2024Noubar AfeyanDirectorSell15,000$121.68$1,825,200.00 5/1/2024Noubar AfeyanDirectorSell15,000$110.92$1,663,800.00 4/24/2024Noubar AfeyanDirectorSell15,000$108.32$1,624,800.00 4/17/2024Noubar AfeyanDirectorSell15,000$103.38$1,550,700.00 4/15/2024Stephen HogePresidentSell15,000$105.02$1,575,300.00 4/10/2024Noubar AfeyanDirectorSell15,000$107.12$1,606,800.00 4/8/2024James M MockCFOSell705$101.93$71,860.65 4/3/2024Noubar AfeyanDirectorSell15,000$101.68$1,525,200.00 3/27/2024Noubar AfeyanDirectorSell15,000$109.06$1,635,900.00 3/20/2024Noubar AfeyanDirectorSell15,000$102.39$1,535,850.00 Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich.3/13/2024Noubar AfeyanDirectorSell15,000$108.54$1,628,100.00 3/8/2024Shannon Thyme KlingerInsiderSell544$99.05$53,883.20 2/29/2024James M MockCFOSell647$94.57$61,186.79 2/29/2024Shannon Thyme KlingerInsiderSell670$94.57$63,361.90 2/29/2024Stephen HogePresidentSell2,388$94.57$225,833.16 2/1/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$99.02$1,001 - $15,0001/16/2024Stephen HogePresidentSell15,000$103.90$1,558,500.00 1/8/2024James M MockCFOSell772$109.75$84,727.00 12/27/2023Stephen HogePresidentSell45,000$100.01$4,500,450.00 12/27/2023Stephen HogePresidentSell45,000$100.01$4,500,450.00 (Data available from 1/1/2013 forward) MRNA Insider Trading Activity - Frequently Asked Questions Who is on Moderna's Insider Roster? The list of insiders at Moderna includes Arpa Garay, David W Meline, James M Mock, Juan Andres, Noubar Afeyan, Shannon Thyme Klinger, Stephane Bancel, and Stephen Hoge. Learn more on insiders at MRNA. What percentage of Moderna stock is owned by insiders? 15.70% of Moderna stock is owned by insiders. Learn more on MRNA's insider holdings. Which Moderna insiders have been selling company stock? The following insiders have sold MRNA shares in the last 24 months: Arpa Garay ($44,183.76), James M Mock ($845,327.35), Juan Andres ($763,400.00), Noubar Afeyan ($112,396,548.88), Shannon Thyme Klinger ($1,478,603.99), Stephane Bancel ($140,083,662.65), and Stephen Hoge ($23,883,116.02). How much insider selling is happening at Moderna? Insiders have sold a total of 2,009,194 Moderna shares in the last 24 months for a total of $279,494,842.65 sold. Which members of congress are trading Moderna? Josh Gottheimer (D-NJ) has sold shares of Moderna in the last year totaling $8,000. Moderna Key ExecutivesMr. Stephane Bancel (Age 51)Chief Executive Officer Compensation: $4.55MDr. Stephen Hoge M.D. (Age 47)President Compensation: $1.92MMr. James M. Mock (Age 47)Chief Financial Officer Compensation: $1.4M3 recent tradesMs. Shannon Thyme Klinger (Age 53)Chief Legal Officer & Corporate Secretary Compensation: $1.39M5 recent tradesDr. Jerh Collins Ph.D. (Age 57)Chief Technical Operations & Quality Officer Mr. Brad Miller (Age 50)Chief Information Officer Ms. Lavina Talukdar CFASenior VP & Head of Investor RelationsColleen HusseySenior Director of Corporate CommunicationsMs. Tracey Franklin (Age 43)Chief Human Resources Officer Dr. Melanie Ivarsson M.B.A.Ph.D., Chief Development Officer More Insider Trading Tools from MarketBeat Related Companies Takeda Pharmaceutical Insider Trades BioNTech Insider Trades Teva Pharmaceutical Industries Insider Trades BeiGene Insider Trades Viatris Insider Trades Summit Therapeutics Insider Trades Genmab A/S Insider Trades Sarepta Therapeutics Insider Trades Catalent Insider Trades Vaxcyte Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:MRNA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
